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ABSTRACT
The knowledge about substance use and treatment among
migrants and ethnic minorities is scarce in the European
Union. In light of recommendations to optimize data gather-
ing and processing, the aim of this paper is to identify which
migration and ethnicity related indicators are used in the EU-
28 treatment demand indicator (TDI) registries. We present
results of a systematic TDI report analysis and an online sur-
vey. Because of the importance of the principles of subsidiar-
ity and proportionality in the European Union, we base the
discussion of the results on survey responses of experts in the
member states. We subsequently discuss considerations
related to 1) optimizing migration and ethnicity related indica-
tors in TDI and other drug related indicator protocols, 2) using
unique identifiers, and 3) enhancing purpose specification and
informed consent. These suggestions are formulated against
the backdrop of the General Data Protection Regulation
(GDPR) as well as the growing need to ground comprehensive








Disparities in the provision of (mental) health care and substance use treat-
ment (SUT) for migrants and ethnic minorities (MEM in what follows)
have been documented extensively across the continents (Kirmayer, 2012;
Saloner & Le^ Cook, 2013; WHO, 2016) but to a much lesser extent in
Europe (De Kock, 2019; Domenig, Fountain, Schatz, & Br€oring, 2007;
EMCDDA, 2013a, Lemmens, Dupont, & Roosen, 2017). Horyniak, Melo,
Farrell, Ojeda, & Strathdee (2016) found that prevalence estimates of haz-
ardous/harmful alcohol use among forced migrants ranged from 17% to
36% in camp settings and 4%–7% in community settings and that male
sex, trauma exposure and symptoms of mental illness were commonly
identified correlates of substance use. Missinne and Bracke (2012) in turn
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found that, independent from residence status, the broader population of
persons with a migration background displayed more depressive symptoms
compared to the general populations in 23 EU member states. Moreover,
only a minority of European member states offer full access to health serv-
ices to undocumented migrants (Cuadra, 2012).
The second European Union Minorities and Discrimination Survey (FRA,
2017) observed that Roma1 - the largest ethnic minority in Europe -
respondents experienced the highest rates of discrimination in access to
health care compared to other national and ethnic minorities. The SRAP
(2012) study on harmful substance use among Roma in turn concluded that
poverty, segregation, low access to education, employment and health serv-
ices are important factors that contribute to substance use in the six studied
Roma communities in Italy, Bulgaria, Romania, Spain, Slovenia, and France.
Preliminary Belgian studies among non-national SUT clients identified
disparities compared to their national client counterparts: lower retention
rates, later first admittance, underrepresentation of females compared to
their national client counterparts (Derluyn et al., 2008), overrepresentation
in substitution treatment, underrepresentation of intra-European clients
compared to their presence in the general population (Blomme, Colman, &
De Kock, 2017). An additional analysis of the same data compared the pro-
file of clients registered as Belgians, EU nationals and non-EU nationals in
the Belgian Treatment Demand Indicator (TDI) registry (2012–2014) and
identified less referral by general practitioners and lower socio-economic
status, especially among third country clients (available on request to
the author).
TDI is the largest reliable drug-related data set in Europe (Montanari
et al., 2019). It informs about met (Ritter, Mellor, Chalmers, Sunderland, &
Lancaster, 2019) treatment demand2 (as opposed to unmet treatment
demand). The objective of the TDI is to collect information in a harmon-
ized and comparable way across all Member States on the number and
profile of people entering drug treatment (clients) during each calendar
year (TDI protocol 3.0, p. 16).
However, although coverage of the register has improved significantly
between 2011 and 2019, not all services active in or related to drug treat-
ment demand participate in the registration (Antoine, De Ridder,
Plettinckx, Blanckaert, & Gremeaux, 2016). Furthermore, in the third TDI
1The term Roma encompasses diverse groups, including Roma, Gypsies, Travellers, Manouches, Ashkali, Sinti, and
Boyash. Roma is the term commonly used in EU policy documents and discussions.
2The first actor who defined a common protocol for collecting data on people entering drug treatment was the
Pompidou Group (PG), who coordinated studies at city level (in Dublin and London in 1991) and a
developmental project in 11 cities and the creation of a European expert group which met several times to
discuss and agree on the methodological guidelines. (TDI protocol 3.0)
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protocol (2012), the “nationality” variable was omitted at the European
Monitoring Center for Drugs and Drug Addiction (EMCDDA) level and
consequently some countries no longer register it.
Privacy versus equality
General recommendation 32 of the Committee on the Elimination of
all Forms of Racial Discrimination (CERD) states that “the principle of
nondiscrimination requires that the characteristics of groups be taken into
consideration.” Moreover, the European Commission against Racism and
Intolerance (ECRI) (in Simon, 2012) specifies that “it is difficult to develop
and effectively implement policies without good data.” ECRI defines equal-
ity data as “statistics broken down by citizenship, national/ethnic origin,
language and religion” (Farkas, 2017a, p. 36).
In the context of HIV-related surveillance among migrants, a report
of the European Center for Disease Prevention and Control (ECDC)
(2011, p. 13) cautions that this type of data gathering
should “do no harm” (… ). This means that if data are collected about “migrants”
it should be done with the intention of benefiting migrants and it should be possible
to provide evidence that this is the case or, at least, that no harm befalls them
as a result of this data collection.
To protect European citizens from these potential harms, the General
Data Protection Regulation (GDPR, 2016) regulates the collection and
processing of personal data. The GDPR explicitly prohibits the collection of
ethnicity related data but also provides quite an array of exceptions includ-
ing “substantial public interest,” “vital interests of the data subject” and
“public health” relevance (art. 9). Furthermore, the collection and process-
ing of (pseudo)anonymized data (Custers et al. 2012, p. 345) is not prohib-
ited when working with unidentifiable unique encrypted personal numbers
(Van Baelen, De Ridder, Antoine, & Gremeaux, 2018) and as long as the
“purpose specification principle” (and subsequent informed consent)
is respected.
Farkas – in a report on equality data gathering commissioned by the
European Commission – argues that “no Member State imposes an abso-
lute prohibition of ethnic data collection. In all Member States, the collec-
tion of ethnic data takes place in accordance with the Data Protection
Directive” (2017a, p. 14).3 Farkas rated the EU-28 member states equality
3For detailed country information we refer to the full country reports (Farkas, 2017c).
JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE 3
data gathering (including but not limited to ethnicity related data) as
presented in Table 1.4
At least eighteen of the EU-28 member states regulate equality data gathering
in their privacy legislation insufficiently, resulting in dispersed interpretation
and adding to the taboo around this type of data gathering. Farkas (2017a) fur-
ther specifies that ethnicity data gathering is not absolutely prohibited in any of
Table 1. Equality data score as presented in Farkas (2017b).
Equality data gathering score (Farkas, 2017b)
Country Regulated Valid Reliable Comprehensive Used
Austria red red orange yellow red
Belgium red yellow yellow yellow
Bulgaria orange orange red green red
Croatia yellow orange orange light green red
Republic of Cyprus red red red orange red
Czechia red orange orange yellow red
Denmark red red yellow yellow orange
Estonia orange orange orange orange red
Finland green green green green light green
France red orange yellow yellow red
Germany red red yellow yellow orange
Greece red red orange yellow red
Hungary light green orange orange orange orange
Ireland yellow light green yellow yellow yellow
Italy red yellow orange yellow orange
Latvia red orange orange orange red
Lithuania red orange orange orange red
Luxembourg red orange orange yellow red
Malta red red orange orange red
Netherlands light green green green green yellow
Poland red orange orange yellow red
Portugal orange yellow yellow red
Romania red orange orange orange yellow
Slovakia red orange red red red
Slovenia red orange red orange red
Spain orange orange orange orange red
Sweden red orange light green red
UK green green green green green
Explanatory note:
The gray scale represents respectively from black to light gray the following colors (Farkas, 2017b, p. 5–6):
- Red (Score 01–19): Major weaknesses;
- Orange (Score 20–39): Areas of Weaknesses;
- Yellow (Score 40–60): Mixed areas of strengths & weaknesses;
- Light green (Score 61–80): Areas of strengths;
- Green (Score 81–100): Major strengths.
4(Farkas, 2017b, pp. 12–21) rated equality data gathering by means of a fixed set of indicators as:
- regulated (in sensitive data exemptions allowed as per Directive 95/46/EC and in anti-discrimination
legislation and the existence of equality data legislation or guidance);
- valid (consultation of populations, coverage of groups, use of self-definition);
- reliable (nationally comparable, regular data collection, number of actors collecting data, controls and
disaggregation);
- comprehensive (presence of population estimation and data on employment, education, housing, health,
poverty/social exclusion, crime victimization, discrimination complaints, discrimination cases, outcomes of
discrimination cases), use of equality data to promote equality in practice (official national monitors
(discrimination, equality, integration), official local monitors (discrimination, equality, integration, proof in
discrimination cases, use of remedies & sanctions, planning for equality or positive actions, law- and policy-
making, evaluation of anti-discrimination legislation).
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the member states and that even in France – often cited as a member state with
absolute prohibition of this type of data gathering – ethnicity data-gathering is
possible by means of the exceptions in privacy legislation.5
Health-related data enjoys an even higher level of protection in the EU
(Convention 108, Article 6). As is the case in GDPR, the 2019
Recommendation on the protection of health-related data (CM/Rec(2019)2)
stresses in its preamble that data gathering should always “aim to serve the
data subject, enhance the quality and efficiency of care, and to enhance
health systems where possible.”
This recommendation subsequently advises member states to ensure that
its principles are enshrined in law and brought to the attention of the
authorities responsible for healthcare systems with the main aim of devel-
oping secure and interoperable information systems. The recommendation
aims at limiting data processing for specified purposes. As is the case for
the GDPR, it includes exceptions related to “reasons of public health, such
as the protection against health hazards, humanitarian action or in order to
ensure a high standard of quality and safety for medical treatment, health
products and medical devices, subject to the conditions provided for by
law” and “reasons of substantial public interest” (2019, p. 5).
A report on “ethnic statistics” and data protection commissioned by the
Council of Europe (Simon, 2007, p. 21) specifies that:
The concept of public interest applies to all areas of public action, and so leaves
legislators relatively substantial scope for removing certain sensitive data from the
protection authorities’ control. It also specifies that scientific research and public
statistics are areas where reasons of public interest apply. This opens the way to the
collection of data which might seem to be prohibited.
Indeed, “public interest” in GDPR and the health-related data recom-
mendation are broad and open to interpretation. Nevertheless, although
“public interest” theoretically opens the way to (secondary) use of migra-
tion and ethnicity related data for research or official purposes, it is rarely
invoked by the member states to register or process this data.
Research question
Monitoring scientifically sound migration and ethnicity related indicators
among SUT clients (on a voluntary basis) can be argued to be
5A French constitutional decision did indeed forbid the inclusion of variables on race and religion in
administrative files but it did not rule on the de facto inclusion of geographic origin or previous citizenship
(available in public statistics) and language related indicators. Farkas concludes that “It is conceivable that as a
result of the Constitutional Council decision, French judicial interpretation is not compliant with the EU Data
Protection Directive concerning the collection of ethnic data, inasmuch as it denies the right to individuals to
consent to the processing of data concerning their ethnic origin while providing a mechanism that generates
such data without their explicit consent” (Farkas, 2017a, p. 14).
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indispensable for identifying health disparities and for understanding and
acting upon the needs of diverse client populations. The aim of this study
is subsequently to identify:
1. What MEM-specific treatment demand trends could be identified in the
EU-28 member states in the national drug reports?
2. Which migration and ethnicity related indicators were used in EU-286
TDI registries in 2017?
Identifying migration and ethnicity related indicators will allow us to
assess their analytical capacity to capture complex ethnicity and migration
related characteristics and treatment demand trends, their compliance with
General Data Protection Regulation (GDPR) and their subsequent transfer-
ability to other European contexts.
Methods
National report analysis
To identify trends concerning drug treatment demand among MEM in the
EU-28 member states we screened the 2014 national drug reports submit-
ted by the EU-28 member states to the EMCDDA by means of the follow-
ing queries: ethn, minorit, migra, nationali, foreign, roma, asylum,
refugee. The 2017 reports that are available online contained little to no
information on treatment demand trends7 among MEM whereas not all
2015 and 2016 reports were available online, as the result of large changes
in the reporting system in 2015.8
I subsequently focused on the 2014 reports9 for in-depth analysis and disse-
minated a survey to identify the indicators that were used in 2017 (see below).
Full paragraphs including the search terms were listed and read per country.
The information was then coded with the intent of framework analysis (Gale,
Heath, Cameron, Rashid, & Redwood, 2013). The framework codes emerged
from the gathered data and are used for the subheadings of this paper: vulner-
able populations, treatment demand, drug-related crime, prison populations,
health/risk behavior data, social correlates and accessibility.
6Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany,
Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania,
Slovakia, Slovenia, Spain, Sweden, UK (England and Wales, Northern Ireland, Scotland).
7The internal document Guide for reporting to EMCDDA 2015 states that the chapter on ‘social correlates and
social reintegration’ – included in all 2014 reports – will no longer be separately included, but integrated in the
treatment chapter in the reporting system as from 2015.
8The reporting guidelines of EMCDDA are re-discussed year by year.
9All 2014 reports are based on 2013 data. Subsequently, if no year is mentioned in the results section, data
refer to 2013.
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Survey on migration and ethnicity related variables in treatment demand
indicator registries
To identify how EU-28 member states monitor migration and ethnicity
related variables, an online survey10 was distributed to the EU-28 member
states via the Reitox National Focal Points by means of a request of the
Belgian National Focal Point (Sciensano). The European Reitox National
Focal Points (NFP) are responsible for submitting the treatment-based
(including TDI data) drug reports to EMCDDA on a yearly basis.
The survey questions aimed at identifying ethnicity and/or migration
related variables registered by means of the 2017 national TDI protocols.
The full survey is available upon request to the author. The survey was
open from 10th to 31st of April 2019. Two reminders were sent by the
Belgian National Focal Point. Two days before closing the survey, the
researcher sent an extra reminder and called all heads of the national focal
points that had not completed the survey to provide the relevant data.
Results
Identified vulnerable populations in TDI
20 out of the 28 national drug reports of 2014 identify MEM populations
that they describe as specifically vulnerable for problem use or remarkably
prevalent in treatment demand registries.11 Eight country reports12 did not
single out a specifically vulnerable MEM population. At least three (France,
Malta, UK) of those countries are reported to explicitly mention the inclu-
sion of MEM populations in social exclusion policies. The UK report
explains that there are no statistically representative samples available to
report about these populations whereas the Polish report explains that no
data is available. The German report in turn indicates that “data on the
prevalence of addiction behavior among people with a migration back-
ground is generally insufficient” (p. 7113).
Populations denominated as “not having the nationality of the member
state” are most prevalent, including but not limited to Greek nationals in
Cyprus, Vietnamese and Chinese nationals in Ireland (in addition to trav-
eler populations), Portuguese nationals in Luxembourg, homeless non-
10The full questionnaire is available upon request to the author. The relevant wording of the questions is
reported in the results section.
11Note that MEM that were only reported about in drug-related crime or judicial statistics are not accounted for
in this section.
12UK, Poland, Denmark, Greece, Portugal, France, Finland, Malta.
13In the results section I only refer to pages in the 28 national reports. These reports are fully available and
were consulted via http://www.emcdda.europa.eu/publications-database_en?f%25255B0%25255D=field_series_
type%253Aname%3ANational%20reports&f%5B0%5D=field_pub_date%3A2014
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nationals in Hungary, and undefined non-nationals in Austria and Italy.
Roma populations are the second most mentioned across the reports,
mainly in Central and Eastern European but also in the Baltic mem-
ber states.14
Problem users with a Russian background (identified by means of their
language or as a “former USSR national”) are the third most mentioned
population, more specifically in the Baltic states and Germany.
Besides these three categories, the Dutch report highlighted vulnerabil-
ities among non-western migrants, the Swedish report speaks of “foreign-
born,” the German and Belgian reports identify populations with a
“migration background”. The German report is in fact the only report that
includes a clear definition of “migration background.”15
Treatment demand
Half (n¼ 14) of the 2014 national drug reports observe numerical trends in
treatment demand among MEM mainly based on nationality registration.
Table 2 presents the full paragraphs that include MEM related TDI data.
Notwithstanding the fact that half of the countries report numerical
treatment demand trends among varying MEM, these numbers are often
left insufficiently contextualized because they report inconsistently concern-
ing comparisons with general population presence (other than the Danish,
Cyprus and German reports) and whether the numbers represent over- or
underrepresentation. The majority of the data is not aggregated per treat-
ment type nor at other levels (except for the Estonian report).
Most importantly the migration or ethnicity related variables are not
analyzed in relation to other correlates (i.e., employment, gender, educa-
tion, housing) and countries do not always identify longitudinal trends.
The “Social exclusion and drug use” parts of the 2014 reports often include
a break-down by employment and education but this is not related to eth-
nicity or migration related indicators in the TDI data. Reports do identify
specific socio-economic vulnerabilities in these populations (i.e., the
Swedish report concerning nationalities of homeless populations and low
employment among third country nationals in the Dutch report) by means
of references to other studies.
Only the Irish report specifically identifies an in-depth study of treatment
demand among a MEM (sub)populations concerning the above mentioned
14Lithuania, Slovakia, Slovenia, Czechia, Romania, Bulgaria
15p. 156 The term, “People with migration background” includes people who came to Germany after 1950 and
foreign nationals born in Germany (including refugees), late repatriates and naturalised persons as well as their
children (Ruf & Walter-Hamann 2014).”
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Table 2. Treatment demand MEM-trends in the EU-28 national drug reports of 2014.
GR In 2013 unemployed users comprise 64.3% of all users who approached drug services. 8.8% of
all users approaching treatment services were homeless users at the reporting year. 7% of
users approaching various therapeutic services in 2013 have foreign nationality. (p. 80)
DA A minor proportion of the drug users receiving treatment are foreign citizens, amounting to
a little over 6% in 2011. The proportion of clients of foreign nationality receiving treatment
almost corresponds to the proportion of foreign nationals in the population as a whole.
(p. 39)
BG The general characteristics of the persons demanding drug-related treatment in 2013 can be
expressed as follows:
predominantly male (81.1%), predominantly Bulgarian (81.8%), General average age – 29.5
years of age, predominantly secondary education (56.2%), predominantly heroin (70.1%),
predominantly daily use (56.4%), predominantly injecting (64.4%), average age at the time of
first use of primary drug – 19.6 years of age. (p. 60)
The relative share of the individuals who have demanded treatment and who do not belong to
the main ethnos of the country has increased more than twice since 2007 and over the past
3 years remained within the 17–18% break, which can be explained by the fact of the
addition of the persons who demanded treatment in the prisons, where the percentage of
the minority groups is much higher. (p. 63)
CY In 2008, a remarkable decrease of opiate HRDUs occurred, partly attributable to some significant
changes in the population used for the estimate, such as a lower number of demands for
treatment, a lack of prison data and a significant decrease of foreign nationals recorded in
treatment. (p. 39)
In particular, as in previous years, foreign nationals accounted for the majority of high risk
opiate users (estimated at about 60% of all opiate HRDUs in 2013) (p. 42).
Regarding the nationality of clients recorded in treatment in 2013, 879 out of 1092 were Cypriot
nationals. Nationals of other countries amounted to 205, the majority of whom were EU
nationals (135), mainly Greek nationals. (p. 52).
As in previous years, significant differences occur in risk behavior prevalence when stratified
by nationality. As in the case of heroin as primary drug, both injecting and sharing practices
are more prevalent among foreign nationals (27.5% of Cyprus nationals with heroin as
primary drug reported ever shared, as compared to 41% of EU nationals). (p. 61)
DE Data from the various recent studies (MoSyD, SCHULBUS, JDH-Study Berlin) confirms that in a
comparison of adolescents from Muslim parent households with other adolescents of the
same age, those with a Muslim background use cannabis and illegal drugs much more rarely.
(p. 43)
The data available on the prevalence of addiction behavior amongst people with a migration
background is generally insufficient. In addition, this population group is too heterogeneous
to enable generally applicable statements to be made as to the addictive behavior of its
members. Rather, the group must be further differentiated into specific sub-categories.
Individual study results are available for the addictive behavior of migrant adolescents. In a
cross-sectional study, Bermejo and Frank (2014) collected data on alcohol consumption
amongst older persons with Turkish, Spanish and Italian migration backgrounds, as well as
amongst repatriates. Overall risky consumption was reported by 9% of respondents.
Repatriates had the highest level (11.4%) and the Turkish group - in which most people,
namely 70.2% are abstinent - had the lowest level (5.3%). Looking at persons who consume
alcohol, the highest value for risky consumption was recorded in the Turkish group (17.6%).
Alcohol consumption of older persons with a migration background is below the average
values for Germans. The findings indicate that persons who consume alcohol from
abstinence based cultures are more likely to develop problem consumption patterns. (p. 71)
In 2013, 78.2% (2012: 78.7%) of all outpatient clients N ¼ 67,03059 with drug problems
recorded within the framework of the German Statistical Report on Treatment Centers for
Substance Use Disorders were male. 50.2% (2012: 50.3%) of all treated patients were between
15 and 29 years of age. 83.3% (2012: 83.2%) of them were of German nationality, 3.2%
(2012: 3.0%) were from other countries of the European Union (EU), 8.4% (2012: 8.6%)
from non-EU countries such as Turkey or the former Soviet Union (unknown nationality:
5.1%). Since living conditions of the clients vary considerably depending on the main
diagnosis or the drugs used, the characteristics presented in Table 5.4 are broken down by
main drugs. (p. 104)
In outpatient and inpatient addiction treatment (K€unzel et al. 2013), the proportion of these
people in outpatient treatment was most recently estimated at 16.8% and the proportion of
those in inpatient treatment was estimated at 13.0%. These figures, however, are not only
related to persons addicted to illegal drugs but also, for example, to alcohol and tobacco
dependent persons (p. 156)
(continued)
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contexts: it documents treatment demand in a specific population, comparing
trends among traveler clients to trends in the general population.
Drug related crime and prison populations
Whereas only half of the country reports include data and trends about
MEM drug treatment demand, more (n¼ 18) reports include information
EE Most of the persons receiving drug addiction treatment (over 80%), just like in the previous
year, were Russians, the percentage of other nationalities was less than 10%. In 2013, the
percentage of Estonians who sought treatment for the first time was somewhat larger
amounting to almost 20%. 38% of all people who sought treatment lived in Tallinn and Harju
County and 59% in Ida-Viru County. However, among the persons who sought treatment for
the first time, the percentages of patients living in Tallinn or Harju County and the Ida-Viru
Country were reversed - 59% of the people who sought treatment lived in Tallinn or Harju
County while 38% lived in Ida-Viru County (p. 38)
GR According to the data from two low threshold services run by OKANA and KETHEA, the profile
of their clients (n¼ 2 552) is as follows: The vast majority were men (80%), the mean age of
those approaching KETHEA low threshold service (n¼ 379) was 37 years, on average, about
one out of three were immigrants, more than half (55%) were homeless and 77.5% were
unemployed. (p. 78)
In 2013 unemployed users comprise 64.3% of all users who approached drug services. 8.8%
of all users approaching treatment services were homeless users at the reporting year.
7% of users approaching various therapeutic services in 2013 have foreign nationality.
(p. 80)
SK Heroin was mainly distributed from suppliers to consumers through Roma families that apply a
similar modus operandi as Albanian organized crime groups. In Central and Eastern Slovakia,
heroin continued to be sold in minimum quantities to relatively closed groups of consumers.
A majority of heroin consumers were individuals of Roma origin involved in its
distribution, and/or long-term heroin addicts. (p. 145)
LV Approximately one third (35.2%) of drug users treated in 2013 are Latvians, about one half
(50.6%) are Russian speaking, one in ten (10.2%) drug users have not provided
information on their nationality, but 7.6% of drug users treated in 2013 represent other
nationalities. Among those first-treated patients whose nationality has been indicated, the
proportion of Latvians is bigger than among previously treated patients (44.6% and 30.8%
respectively). (p. 58)
LU The male/female ratio of the PDU population is stable at 4:1. During the last ten years the
proportion of indexed non-native PDU has shown strong variations but a clearly
increasing tendency since 2003. The population of non-native drug users largely consists
of Portuguese nationals, whose proportion is not consistently lower than the one
observed in general population. (p. 74)
RO Data for HIV infection show double prevalence among IDUs, compared to the previous year. In
terms of the socio-demographic indicators, these define, both for IDUs benefitting from
treatment services and for IDUs benefitting from needle exchange programs, an extremely
vulnerable population, in terms of lack of subsistence means, low level of education, ethnical
component (high prevalence of Roma sub-population in the needle exchange programs)
and anomic behaviors (commercial sex, drug related crimes etc.). (p. 6)
PT The analysis of socio-demographic characteristics of patients who went in 2013 to the different
drug addiction treatment structures continue to be mostly male (74% to 88%), aged 35–44
years (22% to 52%) and 25–34 years (18% to 44%), middle age varying between 30 and 40
years. Continue to be predominantly individuals of Portuguese nationality (93% to 100%)
and singles (48% to 71%). (p. 73)
IE The incidence of treated problem substance use among the Traveler community was three
times that among the general population in 2010 (523 per 100,000 vs 173 per 100,000).
[elaborate study of types and trends] (p. 61)
MA The majority of all treated clients were Maltese Nationals during 2013 (97%), the same as
that for 2011 and 2012. The number of Maltese first treated clients was reported at 94%, the
same percentage as in 2012 and a slight decrease of 3% from 2011 (97%). Treated clients
coming from other EU countries in 2013 remained stable at 2% of the entire service using
population as in 2011 and 2012. (p. 49)
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about drug-related crime or nationalities in judicial statistics. The type of
data reproduced includes foreign arrestees, convictions of non-nationals,
non-nationals detained with drugs, prison population data, drug-related
crime, and aggravated narcotic offenses. Some countries reported quite
high non-national prison populations (Cyprus: 50%) or non-national
involvement in drug-related crime as reflected in prison populations
(Finland: 39%, Spain: 1/3, Portugal: 28%) while other countries report
that these numbers decline and/or have always been quite low (Czechia:
9%, Italy: 17% [but also over 30% unknown], Greece: 8%, Bulgaria
[no numbers]).
However, no real trends can be discerned because country reports do not
report uniformly and numbers are rarely presented in relation to a broader
context. It is for example unclear whether the populations included in these
drug related crime or judicial statistics do or do not overlap or are related
to trends in treatment demand data. This is for instance particularly the
case for the populations denominated as “ethnic Albanian” in the reports
of Slovakia, Czechia and Croatia as well as Russian populations in Finland,
ethnic Vietnamese in Slovakia and non-EU nationals in Italy, Spain,
and Luxemburg.
Only the Romanian and Lithuanian reports mention that Roma popula-
tions in the capital are involved in both drug markets and problematic use
of heroin but this is not documented with numbers. Similarily, the Irish
report gives insight in a prison subpopulation with Asian backgrounds,
detained for involvement in cannabis production but identified as having
been lured by human traffickers and forcedly involved in cannabis cultiva-
tion. Lastly, the Slovakian report notes that “distribution of heroin to users
is obviously provided by Roma families” (p. 19) but does not include
references to numbers, observations or the relation of this statement to
treatment demand.
Some country reports (i.e., Luxemburg, Sweden) emphasize that no real
trends among non-nationals involved in drug related crime can be
discerned. The French report does not include numbers but does report
that data is available per nationality about different types of offenses, con-
victions, types of procedures, nature and duration of the sentences (p. 147).
Health correlates and high risk drug using behaviors
Those country reports that include MEM numerical drug treatment
demand trends16 more often also included specific information on
correlated health risks and risky drug use, compared to countries that did
16Greece, Denmark, Bulgaria, Cyprus, Germany, Estonia, Slovakia, Latvia, Lithuania, Luxemburg, Romania,
Portugal, Ireland, Malta.
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not observe these trends. Some country reports observe that among persons
newly registered with infectious diseases a certain proportion consists of
non-nationals. Concerning HIV in Sweden, 12 of 14 newly registered HIV
cases among persons who inject drugs (PWID) in 2013 were reported to
have been infected abroad. But the total number is low and declining. In
Bulgaria and Slovakia these numbers were similarly low, respectively 12
and 5%. In Greece, between 2011 and 2013, 23% of newly infected HIV
were non-nationals (p. 60). Concerning HCV (Hepatitis C) in Cyprus, the
majority of HCV positives (23 out of 39 cases) were non-nationals (1/2
Greek, 1/4 other EU, 1/4 non-EU).
Additionally, in Estonia, the prevalence of infectious diseases in 2013
among Tallinn PWID was higher among those with a Russian nationality.
Also in Estonia, 70.2% of the overdose victims (mainly fentanyl-related)
were ‘ethnic Russians’ (n¼ 78). However, overdose deaths were generally
declining. In Italy, 9% of the overdose deaths involved non-nationals. This
was the case for 27% of the overdose deaths in Luxemburg. Additionally,
a decreasing number of victims of Portuguese nationality was observed
in Luxemburg.
High risk drug use related behavior was also accounted for in some of
the reports. A lower starting age for illegal substance use was reported
among Roma in Czechia. In Cyprus, most high risk drug users were non-
nationals and in 2013 injecting and sharing practices became more preva-
lent in this population. In Estonia too, injecting drug users mainly had
a Russian nationality. Higher injecting prevalence was also observed among
female travelers compared to male travelers in Ireland, while when leaving
gender unaccounted for, injecting practices were similar to those in the
general population.
Social correlates
Half of the countries that report on treatment demand17 in varying MEM
populations, mention social correlates to problem drug use among MEM
populations. Homelessness, unemployment, low education and being
undocumented are the social correlates that are most mentioned in these
country reports. The Dutch report for instance reports that “the proportion
of non-Western migrants among the homeless people was 40%” (p. 83)
whereas the Swedish report notes that among homeless non-nationals
“one fourth had no other known problem besides their lack of housing, compared to
14% of the Swedish-born. The most usual reason for being homeless in the foreign-
born group is not being approved on the regular housing market” (p. 71) and “the
17Greece, Denmark, Bulgaria, Cyprus, Germany, Estonia, Slovakia, Latvia, Lithuania, Luxembourg, Romania,
Portugal, Ireland, Malta.
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income gap has increased. Poverty is increasingly more common among immigrants”
(p. 67). These correlates are equally mentioned in nine country reports that did not
include an analysis of treatment demand among MEM.18
Four country reports quote survey data that indicates higher unemploy-
ment among non-Western migrants (Netherlands), concurrence of risk
factors (substance use, homelessness) (Spain) and higher unemployment
among non-nationals compared to nationals (Austria, Latvia). However, as
mentioned above, none of the reports study these issues as correlates in the
available TDI data (see Table 2).
Access
All EU-28 2014 country reports refer to national strategies intended to
increase the accessibility of SUT services. Countries such as Czechia,
Austria, Poland, Estonia and Romania mainly focus on increasing the geo-
graphical availability of opioid substitution treatment to assure equitable
access. Country reports also focus on targeting especially vulnerable
populations such as drug using prison populations (i.e., Bulgaria, Spain,
Denmark) and HIV positive substance users (i.e., Lithuania, Greece, Latvia,
Luxemburg, Slovakia).
Moreover, country reports mention universal health coverage for all
citizens (i.e., France, Denmark, Bulgaria, Slovakia, Portugal) enabling access
to SUT. Nevertheless, not all citizens have access to SUT, especially not
when persons demanding treatment do not have a national identification
number or social security number (i.e., Croatia). However, only the
German, Luxemburg, Irish, and UK reports specifically mention MEM
populations when discussing accessibility. None of the country reports
(except for the French) make reference to the degree of access to drug
treatment for undocumented MEM.
Migration and ethnicity related indicators in treatment demand registries
The survey had a response rate of 68%, including two additional respond-
ents who provided information via telephone and sent documentation to
the researcher. Data was collected about 1919 of the EU-28 member states.
Respondents all were staff members and researchers, mainly and as
intended of the Reitox National Focal Points.
18Austria, Czechia, Lithuania, Netherlands, Poland, Slovenia, Sweden, Croatia, Spain.
19Belgium, Bulgaria, Cyprus, Czechia, Finland, France, Greece, Ireland, Italy, Latvia, Lithuania, Luxemburg, Poland,
Portugal, Slovakia, Spain, Sweden, The Netherlands, United Kingdom (England). No data available on Austria,
Croatia, Denmark, Estonia, Germany, Ireland, Hungary, Malta and Romania.
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Concerning the indicators used20, all respondents answered the question
“which migration/ethnicity/nationality related indicators were registered in
the 2017 national TDI protocol?” Considering that only two respondents
chose the “other” option (see below) we presume that the answer options
had sufficient coverage. The used indicators are listed in Table 3.
Two respondents answered that they did not record migration or ethni-
city related variables. One respondent answered that this data is not avail-
able and that “only the number for foreigners is available”. Five
respondents only ticked one option whereas the other respondents indi-
cated that they cover two to three indicators. Only one respondent indi-
cated recording “birthplace/nationality mother or father” and one
respondent reported recording a language related question.
Concerning the methods of registration21, the majority of the respond-
ents (n¼ 12) indicate that “providers tick one or several predefined catego-
ries.” Three respondents indicate that open answers by the provider are
also available in addition to predefined ticking. One respondent reported
that only an open ended registration is possible.
All respondents reported insufficient coverage of the ethnicity and
migration related indicators22 because of a low number of services that
register TDI or a low number of identifiable clients in TDI registries. In
some countries, most government funded SUT services register TDI. In
most countries, SUT services consist partly of private services that often do
not register TDI. Furthermore, TDI registration is often not mandatory
which is why some services sometimes do not register it. Respondents also
observe that many clients are not registered with a national identification
number (NIN), especially those clients with a migration background and
those who do not have a NIN such as undocumented migrants. A respond-
ent specified for example that:






Nationality at birth (n¼ 4)
20“Birthplace, European/not-European choice, Nationality at birth, Nationality, Language related question,
Birthplace/nationality of mother, Birthplace/nationality of grandmother, Birthplace/nationality of father
Birthplace/nationality of grandfather, Ethnicity, I don’t know, None, Other (Please specify).”
21Based on the question “Can you specify how migration/nationality/ethnicity related indicators were mainly
registered in the 2017 national TDI protocol?”
22Based on the question “Please name the (types of) services of which (you think) registered nationality/migration/
ethnicity related in 2017” and “Are clients registered with a national identification number in drug treatment in
your country?”
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Registering ethnicity is illegal in [member state]. Our TDI data is pseudo-anonymised
and cannot be linked to other register data. Birthplace, Nationality at birth, Nationality,
Mother tongue, Birthplace/nationality of mother and Birthplace/nationality of father are
available in the national population register and by applying data permissions for specific
studies, it would be possible to link this data to general health care registers. They are
not, however, very useful for assessing drug-disorders because of under-reporting.
Lastly, we asked respondents in an open ended question how they believe
monitoring MEM presence and trajectories in drug treatment could
be enhanced in their country. Clearly, the registration of these types
of indicators is considered sensitive or even prohibited in some countries,
as demonstrated in the quote below.
It is very difficult in [member state] to get data through studies on migrants, non-
nationals, not to speak of ethnicity which is a taboo subject. To any attempt to do so
will be opposed the fear of discrimination. The only possible approach for these
subjects seems to carry out qualitative studies.
Answers to this question are very diverse but complement one another.
Four respondents did not provide answers on how to enhance registration
or data processing. Respondent answers were categorized and are summar-
ized in Table 4. These answer categories are used to structure the discus-
sion. The discussion is based on these survey responses because of the
importance of proportionality and subsidiarity in the European Union.
This means that in domains in which the European Union does not have
exclusive competence, member states are expected to initialize change and
that EU action shall not exceed what is necessary to achieve the objectives
of the Treaties. In other words, a discussion on how to enhance TDI regis-
tration and data processing, can only be initiated based on the perspectives
of national experts in the field.
Discussion: A heated debate
In light of public interest, our results demonstrate that over half of
the 2014 national drug reports observe trends in treatment demand and
highlight important social correlates to harmful substance use and
treatment demand among MEM. Nevertheless, the reports insufficiently
contextualize specific numbers or substantiate and explain trends clearly to
be able to act upon them. Eastern and Central European countries clearly
Table 4. Summary of how survey respondents believe monitoring migrant and ethnic minority
presence in drug treatment could be enhanced.
Reliable indicators and registration in TDI (n¼ 5)
It is sensitive and/or prohibited by law (n¼ 3)
Use of unique identifiers in the TDI dataset (n¼ 3)
([pseudo]anonymous) database linkage (n¼ 2)
Stratify available TDI data (n¼ 2)
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observe disparities among Roma and general populations but cannot
pinpoint reasons and ways forward because of inconsistent data and a lack
of harmonized processing guidelines. This is similarly the case for Russian
speakers in Latvia, Estonia, Germany and more recently in France (Jauffret-
Roustide, Serebroskhaya, & Chollet, 2017) as well as non-nationals in
Cyprus, Ireland, Luxembourg, Hungary, Austria, Sweden, and Italy.
Moreover, persons defined as having a migration background (at least one
parent with other nationality/birthplace) are identified as specifically vulner-
able in Belgium and Germany. Lastly, it should be mentioned that trends in
treatment demand among the growing group of intra-European migrants,
asylum applicants and undocumented migrants in Western, Northern and
Southern European countries are left unstudied in the 2014 country reports.
Indeed, the data used in these reports dates back about five years at the moment
of writing. Nevertheless, new (intra-European) migration movements had
already initiated due to the accession of Central and Eastern-European countries
in the EU in 2007. Although irregular third country arrivals in the EU only
peaked in 2015, the number was already growing in 2013.
Even though the research domain of SUT among MEM is still limited
in the European context there are clear indications of disparities in these pop-
ulations across the EU-28 member states. Subsequently, ethnicity and migra-
tion related data gathering in TDI could be argued for on the basis of public
interest if privacy regulations are respected. In what follows, we first elaborate
on the ways survey respondents believe monitoring MEM presence and tra-
jectories in drug treatment could be enhanced and then discuss the import-
ance of purpose specification and subsequent informed consent.
Sensitive and prohibited?
Three respondents indicated in the survey that this type of data collection
is sensitive or prohibited in their country. This type of data collection is
indeed the subject of heated debate in Europe, mainly because of its ethical
implications for the populations being registered and “categorized” (Jacobs
et al., 2009). The main argument of proponents of migration and ethnicity
related data gathering is based on a perceived need for documenting
(in)equalities related to (health) rights of population groups (Krizsan, 2001)
whereas opponents mainly refer to concerns about privacy (Should
treatment data aggregated at migration or ethnic background level be made
available and if so to whom?) and self-determination (What will be the
consequences of lumping individuals together in categories of persons with
a migration background?) (Varcoe, Browne, Wong, & Smye, 2009).
Especially in the health domain it has been argued that it can “work to
reify, perpetuate and spread into the area of healthcare politically driven
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notions and categories of nationalism which exclude certain groups”
(Helberg-Proctor et al., 2017). We have argued elsewhere that the analysis
of static ethnicity related categories in epidemiological research that lacks
the consideration of correlates and consequent analysis of cross-categories
can indeed work to reify and stigmatize subpopulations (De Kock, Decorte,
Vanderplasschen, Derluyn, & Sacco, 2017).
However, it appears that European member states interpret the GDPR and
its predecessors very differently and as a result only a minority registers such
data in health, census or other registries. The main problem appears to be
that national legislation and resultant regulations do not contain specified
definitions of the equality grounds (i.e., “race,” “ethnicity”). As a conse-
quence, member states insufficiently regulate the indicators and processing of
equality data in the light of public interest. It should be noted that in the EU-
28 only two countries - UK and Ireland - collect data on ethnicity with the
aim to implement positive action (Escafre-Dublet & Simon, 2011).
In any case and in conformity with the GDPR, National Data Protection
Authorities should regulate and control compliance with the lawfulness of data
processing and should supervise that “processing is necessary in order to pro-
tect the vital interests of the data subject or of another natural person”
(GDPR, 2016, art. 6). Furthermore, the GDPR requires that before data regis-
tration and processing takes place, a Data Privacy Impact Assessment be made
and that Data Protection Officers at the organizational level secure that no dir-
ect or indirect harm is inflicted upon data subjects as a result of data registra-
tion or processing.
This implies that advocates of minority rights and anti-discrimination policy
on the one hand and proponents of personal data protection on the other hand
should not per definition take opposite stands. Moreover, protecting individual
privacy and the right to equal treatment can be considered two sides of the same
coin: pursuing the integrity of all individuals (including privacy and equal treat-
ment) in society in line with the Universal Declaration of Human Rights.
Reliable indicators in TDI
Five respondents indicated that more reliable registration could enhance
monitoring MEM in European SUT. The fact that nationality was most
reported by survey respondents to be registered in national TDI registries
is a direct result of its inclusion in the second TDI protocol. The strength
of already having the nationality variable integrated in at least one third of
the EU-28 national TDI protocols should not be underestimated, consider-
ing the compatibility needs when making changes in a registration protocol
in the interest of longitudinal analysis (Krizsan, 2001). With sufficient cover-
age (both in terms of client totals as in terms of treatment services covered) it
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can give insight in the specific group of first generation migrants in SUT (i.e.,
an estimated half of the 2018 MEM population in Belgium). Even if coverage
is limited, member states could choose to monitor registration shortcomings
scrupulously in order to report on parts of their TDI datasets. The nationality
indicator does need rewording in specific national contexts (and with answer
options conforming to ISO 3166 including a “none” option) because in
some EU countries “nationality” could be interpreted as an ethnicity related
indicator (i.e., Cyprus, Romania, Estonia).
Nevertheless, the nationality variable is indeed a flawed proxy to cover all
migration and ethnic backgrounds because it does not capture the complexity
of migrant generations or (multiple) self-definitions (Hunt, 2017; Kolind &
Hunt, 2017). Additionally, the “European/non-European” indicator reported
to be used in at least three member states is insufficiently valid considering
the changing composition of the EU member states and the difference
between countries pertaining to the EU on the one hand and European coun-
tries on the other hand.
A way forward concerning monitoring second generation migrants could
be the inclusion of an indicator concerning birthplace of mother to the
example of European surveys (i.e., European Labor force, health and social
surveys, EU-SILC) and a language related question (mother tongue, home
language [i.e., International PISA questionnaire] and possibly a third lan-
guage related question). A minimum, medium and in-depth registration scen-
ario for TDI is subsequently proposed in Table 5 below.
The use and processing of these indicators in European surveys and their
acceptance in the EU-28 member states that partake in the surveys, indi-
cates validity and conformity vis-a-vis current national privacy regulation.
Additionally, the use of these indicators could be generalized to other
registries (i.e., national health surveys) which could contribute to data com-
parability and multi-indicator analysis. These indicators are not intended to
capture self-identification but rather to capture the situation of objectifiable
social groups. It should be noted that self-identification (see below) is an
added value for qualitative understanding but has been described in litera-
ture to be insufficiently discriminatory to capture migration backgrounds
(Perrin, Dal, & Poulain, 2015).
A second way forward is the consultation of Eastern and Central European
member states to collaboratively (with member state representatives and
targeted populations) consider the inclusion of ethnicity related (in com-
bination with other) indicators. This issue will become increasingly import-
ant because inequalities among Roma populations are no longer only a
concern in Central, Eastern and Baltic European countries but increasingly
require attention in Western, Northern and Southern European countries
too (AC Company, 2005; ERRC, 2017).
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Concerning registration of the indicators, self-definition is considered to
do most justice to the right of self-determination and to define ethnicity
and migration background (Aspinall, 2017; Krizsan, 2001; Varcoe et al.,
2009). The definition of ethnicity and migration background by thirds such
as the police and justice actors should therefore be evaluated critically
because the resulting numbers may not be correct and possibly harm the
data subject and/or depicted populations (Krizsan, 2001). However, self-
definition complicates data collection and analysis (lack of uniform and
exclusionary units of analysis), especially in the SUT context. Also, it has
been argued that strict self-definition is arguably the best method or suffi-
ciently valid when the purpose is to analyze the impact of perception by
others (i.e. perceived and structural discrimination) (Ringelheim & De
Schutter, 2010, p. 135).
Our results demonstrate that the majority of TDI data is registered by
means of the provider ticking predefined categories. The option of open-
ended self-identification alongside the choice of predefined categories, is a
valuable addition to ticking predefined categories, in line with the right to
self-determination.
Multivariate analysis in TDI datasets
Two respondents indicated that the in-depth analysis of current TDI data-
sets will be sufficient to gain more insight into treatment demand among
MEM populations. Indeed, some current TDI datasets already hold the
potential for informing positive action towards certain MEM populations.
However, identifying complex patterns and trends in treatment demand
and nuancing the identification by means of migration and ethnicity related
indicators, requires intersectional analysis (Agirdag & Korkmazer, 2015; De
Kock et al., 2017). Indeed, only relating identified populations in one-on-
one relations to health risks, risky drug use behavior, drug-related crime or
prison-populations is insufficient because it provides little information on
real treatment demand trends. Furthermore, it could in fact harm the
population being described by adding to stigma or discrimination. Madeira,
Table 5. Proposal for minimum, medium, and in-depth registration.
Type of registration
Number of






Medium 3 or 4 Country of birth mother
(Country of birth father)
Second migration generation






Ethnicity related language use
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Pereira, Gama, & Dias (2018) for instance found that perceiving MEM as a
threat or risk to public health (i.e., concerning HIV among high drug users
as mentioned in some reports) is indicative for health providers self-
reported bias in treatment, a bias directly related to lower qual-
ity treatment.
This implies the analysis of two sets of combined variables. First, the process-
ing of at least two and preferably more reliable migration and ethnicity related
variables (see Table 5) will allow for contextualizing the seemingly static cat-
egorization of individuals in groups or populations. Indeed, individual data
should not be used only to characterize a group but also to identify combined
characteristics as well as longitudinal trends and subgroup changes.
Second, migration and ethnicity related variable analysis should be
studied intersectionally in combination with covariates such as living situ-
ation, education, employment and gender in relation to treatment demand
(Giritli Nygren & Olofsson, 2014). This combined study will give in-depth
insight into both the construct of ethnicity, the impact of migration/ethni-
city and might broaden micro-centred epidemiological studies by explain-
ing treatment demand trends (Carliner, Delker, Fink, Keyes, & Hasin, 2016;
Kapilashrami, Hill, & Meer, 2015). The “guide for assessing health needs
and health protection resources” developed with the support of the
European Health program (Makonnen, 2016) could be a valuable resource
in addition to the EMCDDA processing and reporting guidelines.
Moreover, it should be noted that none of the 2014 national drug reports
compare treatment demand to population based prevalence rates among
MEM besides the German and the Swedish reports. In this context, Ritter
et al. (2019) argue for the deployment of models that include treatment
demand and need (substance use prevalence) when estimating real treatment
gaps for the purpose of local treatment planning. These models should also
allow us to distinguish between drug types, age groups and drug use severity
(Ritter et al., 2019, p. 25) and focus on subsequent “tiered” modeling based
on multi-indicator analysis for targeted service planning.
A way forward in the European context could be to a priori add add-
itional purposive sampling strategies to the National Health Surveys in
order to routinely collect data in representative MEM samples on (spectra
from harmful to recreational) substance use prevalence or setting up tar-
geted surveys that complement general population studies, to be included
in the national drug reports. Furthermore, the currently used indicators
(i.e., nationality, birthplace, EU/not-EU) should always be contextualized
by means of representation in the general population or other population
based studies. It would also be informative if country reports could inform
consequently on why specific information is not provided (i.e., the UK
report mentioned that representative datasets were not available).
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The use of unique identifiers in the TDI datasets
The use of unique identifiers in the TDI datasets was suggested by three
survey respondents to better monitor treatment demand among MEM.
If a unique identifier is not available (i.e., first letters of name and first two
numbers of birthday), data cannot be analyzed at the individual disaggre-
gated level (disabling the study of correlates). The growing group of
undocumented migrants for instance that do not possess NIN (yet) are not
identifiable in datasets if NIN is the only identifier used. A last way
forward in order to not rely on NIN, could thus be the consideration to
create unique (pseudo)anonymized TDI identifiers for each client.
Lastly, database linkage (i.e., TDI and population registries) for gaining
insight in treatment demand, as suggested by two respondents, could be
problematic and holds the risk of harmful use of datasets (i.e., small and
identifiable subsets, opening the possibility for linkage to judicial databases
in insufficiently regulated data environments). Database linkage is reported
to be rare in the domain of ethnic data collection in Europe (Farkas,
2017a,b,c) and to our knowledge limited in the drug treatment domain
(Van Baelen et al., 2018). Moreover, linkage of population-based adminis-
trative data is limited by many methodological challenges such as bias from
linkage errors located in the data linkage environment, privacy preservation
procedures in data preparation and the choices of linkage methods.23
Additionally, in the niche domain of MEM in drug treatment, database
linkage is likely to be unreliable because it requires clients to be registered
with a unique identifier that is equally identifiable in other databases such as
a national identification number (NIN). Persons with a different nationality
have been reported to be more often registered without a NIN (i.e., 40.72%
non-identifiable third country and 37.51% European clients in 2012–2014
datasets compared to 23.86% of Belgian clients).
Although database linkage could offer insights in high quality subsets
of data, it would be advisable at this moment to limit data analysis on this
specific topic only to TDI datasets. Only member states that have high quality
datasets (valid indicators, coverage etc.) and that provide sufficient safeguards
for the privacy of data subjects should consider linkage of TDI to other data-
sets for further analysis.24
23In the Netherlands for instance some argue that while ethnicity is included in the health domain to combat
disparities, it might be intertwined with and contribute to these very societal dynamics which produce health
inequalities. This was similarly argued for by Epstein (2007) in stating that the political context in the US shaped
scientific practices related to ethnicity and race in health, as exemplified in US based epidemiological studies
(De Kock et al., 2017).
24More information on TDI database linkage in other domains can be found in Van Baelen et al. (2018).
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“Do no harm”: Purpose specification and informed consent
Rallu and colleagues (2004) argue in favor of data collection regimes that do not
simply aim to document and count but that clearly and explicitly aim at imple-
menting positive action in the light of equality regulations (in Escafre-Dublet,
2011). Indeed, the raw data can be misleading if the data are not considered in
relation to other characteristics such as age, sex and SES (WHO, 2010, p. 8).
Subsequently, it is essential to consider purpose specification scrupulously.
The TDI protocol 3.0 describes the purpose of data collection as follows:
“gain insights into the characteristics, risk behaviors and drug use patterns of
people with drug problems in the community, and to help to estimate trends
in the extent (prevalence and incidence) and patterns of problem drug use”
(2012, p. 17). One could however argue to take this a step further and include,
to the benefit of (and to explicitly protect) the populations involved (and their
subsequent willingness to provide data) the purpose of combatting inequities
and disparities. The 2018 UK “National Drug Treatment Monitoring System”
protocol for instance, introduces with the following sentence: “Public Health
England exists to protect and improve the nation’s health and wellbeing, and
reduce health inequalities.” This addition to the protocol could be decided
upon on the level of a member state or the EU level.
Purpose specification in turn is closely intertwined with voluntary
informed consent by the data subject. Studies do indeed observe that per-
sons identifying with stigmatized populations are often “reluctant” to iden-
tify as such out of fear of stigmatization (Varcoe et al., 2009). This in turn
results in their underrepresentation in statistics. However, the nature of
data collection methods and use of data without proper purpose
specification (i.e., invalid proxy by interpreting only language to identify
“ethnicity,” “choosing” nationality in census contexts, involuntary ethnicity
registration in police statistics etc.) are likely to influence this suspicion.
Moreover, the 2015 Eurobarometer asked whether individuals would
support providing personal details on an anonymous basis if it could help
to combat discrimination in their country and 72% were in support regard-
ing data on “ethnic origin” (Makkonen, 2016). Although individuals with
a Roma background were less favorable, still over half of the surveyed
respondents with this background, were in favor. Although it can be time
intensive for service providers, it is advisable for the national TDI protocols
to include a clear statement on purpose specification to support the service
provider responsible for registration in explaining it to the client.
Purpose specification and informed consent could thus be translated in
1) specifying the purpose of TDI (at member state or EU level) and 2)
involvement of target populations in defining variables and subsequent
involvement of, for instance, the ombudspersons for Minority Rights in the
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member states. Indeed, the quality of the data highly depends on the data
supplier’s interest in the produced data (Krizsan, 2001, p. 281).
Conclusion
Treatment demand trends and socio-economic contexts of MEM populations
are very diverse across the national contexts of the EU-28 member states and
consequently do not always allow for comparisons. However, the current
study demonstrates that the TDI dataset – as a result of the efforts of stand-
ardization initialized by the Pompidou group over two decades ago and
continuously sustained by EMCDDA and the National Reitox Focal Points –
provides a valuable tool when it comes to identifying treatment demand
trends across the EU-28 countries. The existence of this dataset enables know-
ledge transfer across the countries and informs joint policy planning without
interfering with the principles of subsidiarity and proportionality.
Although some respondents expressed legitimate concerns related to
privacy legislation, the majority of survey respondents in the current study
formulated complementary measures to enhance trend monitoring concern-
ing MEM drug treatment demand. Because of the importance of the princi-
ples of subsidiarity and proportionality in the European Union, I focused
the discussion of the results on the suggestions made by survey responses
of Reitox National Focal point staff members. Departing from the idea that
drug (treatment) policy is best based on “tiered modeling” (Ritter, 2019),
this paper suggests to focus prioritarily on the use of reliable migration and
ethnicity related indicators in TDI and other drug related indicator proto-
cols, multivariate and cross-category TDI analysis, the use of unique identi-
fiers and purpose specification in the TDI protocol.
Providing guidelines and support on how the existent data can be
enhanced, processed and safeguarded as well as continuously improving the
quality and coverage of the dataset might allow the member states to relate
prevalence rates (health surveys), treatment demand and data on social cor-
relates to identify meaningful trends and inform targeted service planning.
Processing TDI data should always comply with the GDPR, thereby
avoiding increased stigma of specific populations and preventing harm for
data subjects resultant of data collection and processing. In the light of
growing political conservatism and identity politics in the European Union,
the GDPR requirement of providing a Data Privacy Impact Assessment
and consequently identifying safeguards to reduce the risks of migration
and ethnicity related data registration and processing, is key. This paper
could be a point of departure for developing such an Impact Assessment.
In conclusion, this paper argues, together with other European scholars
and policy makers (Farkas, 2017a; Ringelheim, 2011) for the necessity to
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include scientifically sound migration and ethnicity related indicators that
allow us to monitor (changing) MEM (sub)populations in the drug treat-
ment domain and for processing this data intersectionally, in light of the
specific purpose of serving their (public) interest.
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